Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 7489 - 7496 of 12085 results

New York Delays Cybersecurity Rules for Banks/Insurers Until March 1, 2017
January 5, 2017| Blog| Viewpoint

Health Care Enforcement Review & 2017 Outlook: Important Case Law Developments
January 5, 2017| Advisory| Viewpoint

Health Care Enforcement Review and 2017 Outlook: FDA's Wide-Ranging Activities
January 4, 2017| Blog| Viewpoint

Join Mintz and ML Strategies as We Kick-Off Our 21st Century Cures Act Webinar Series
January 4, 2017| Blog| Viewpoint

#MLWashingtonCyberWatch: 2017 FTC and Google Complaint
January 4, 2017| Blog| Viewpoint

Join Us on January 12th for the Fifth Installment in Our EU General Data Protection Regulation Webinar Series
January 3, 2017| Blog| Viewpoint

Health Care Enforcement Review and 2017 Outlook: Yates Memo in Action
January 3, 2017| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
